Skip Navigation

Updates & Events

Updates & Events

Recent News and Events

Fredrikson & Byron strives to provide clients current business developments and legal updates. See the list below for our most recent updates and events.

Service Approach

We are dedicated to understanding our clients, their business goals and the industry-specific legal issues they face.

Read More

Turkey Announces Several Developments

Turkey announces a New Online Visa Filing System for Consular-Issued Visas as well as proposed changes in Turkish Visa and Immigration Policy.

View Details

Don’t Put All Your Eggs in One Basket on a Preliminary Injunction Motion

Preliminary injunctions in patent litigation are tough to win at the district court. Even if you do, you may still need to defend the decision at the Federal Circuit. 

View Details

Fredrikson & Byron Represents Bio-Techne Corporation in its Acquisition of Zephyrus Biosciences, Inc.

Fredrikson & Byron acted as legal counsel to Bio-Techne Corporation in its acquisition of Zephyrus Biosciences, Inc.

View Details

European Union and Colombian Visa Waiver Agreement

The European Union (EU) and Colombia have signed a short-stay visa waiver agreement.

View Details

Beijing Work Permits

Companies filing for work permits in Beijing must receive preapproval.

View Details

Brazil Publishes a New Resolution

A new Normative Resolution (No. 118) has been published.

View Details

Belgium Sets New 2016 Salary Thresholds

Belgium sets new 2016 salary thresholds for some fast track work permits B and the Blue Card.

View Details

Security Measures: An Overview

This article provides an overview of recent immigration developments in security measures in several countries implemented in response to terror attacks and related concerns.

View Details

DOL Issues Final Conflict of Interest Rule

On April 6, 2016, the Department of Labor issued its much-anticipated conflicts of interest final rule.

View Details

Fredrikson & Byron Represents Omnis Pharma in Merger with Magnis Therapeutics to Become Vyriad

Fredrikson & Byron acted as legal counsel to Omnis International Co., d/b/a Omnis Pharma, in its merger with Magnis Therapeutics, LLC. 

View Details